Search
Androgen-deprivation therapy, a mainstay of prostate cancer treatment, may give prostate cells new growth abilities, scientists at Memorial Sloan Kettering have found.
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.
Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.
Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
GSK congratulates ten of its doctoral students who have been recognized by esteemed organizations for their promising academic research.
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
Brittany Woods, who is completing her doctoral work in the laboratory of physician-scientist Ross Levine, has received a pilot award from the National Cancer Institute that supports outstanding PhD candidates
These souped-up versions may help overcome some limitations of existing CAR T cells.
Researchers led by scientists at Memorial Sloan Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the January 12 issue of Cell.